AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 23 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,266,000 | -37.6% | 5,000,000 | -33.3% | 0.01% | -25.0% |
| Q1 2022 | $6,840,000 | -39.1% | 7,500,000 | -43.3% | 0.01% | -33.3% |
| Q4 2021 | $11,235,000 | +34.1% | 13,218,000 | +43.4% | 0.01% | +33.3% |
| Q3 2021 | $8,376,000 | -51.7% | 9,218,000 | -47.1% | 0.01% | -52.6% |
| Q2 2021 | $17,331,000 | +2.3% | 17,418,000 | +6.7% | 0.02% | -9.5% |
| Q1 2021 | $16,936,000 | +46.0% | 16,318,000 | +30.4% | 0.02% | +40.0% |
| Q4 2020 | $11,603,000 | -32.9% | 12,518,000 | -41.0% | 0.02% | -37.5% |
| Q3 2020 | $17,298,000 | – | 21,218,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
| PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
| DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
| Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
| DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
| Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
| Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
| Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |